Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
5,332.00
+99.00 (1.89%)
May 13, 2025, 3:30 PM JST
Kobayashi Pharmaceutical Revenue
Kobayashi Pharmaceutical had revenue of 32.61B JPY in the quarter ending March 31, 2025, a decrease of -10.63%. This brings the company's revenue in the last twelve months to 161.72B, down -8.36% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.
Revenue (ttm)
161.72B
Revenue Growth
-8.36%
P/S Ratio
2.41
Revenue / Employee
44.74M
Employees
3,615
Market Cap
389.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Japan Tobacco | 3,236.41B |
Seven & i Holdings | 10.34T |
Ajinomoto Co. | 1,530.56B |
Asahi Group Holdings | 2,939.42B |
Kao Corporation | 1,652.51B |
Pan Pacific International Holdings | 2,176.10B |
Unicharm | 980.22B |
Kirin Holdings Company | 2,338.39B |